Multi-cancer risk prediction in asymptomatic adults using urinary…
A urine test identifies people at very high cancer risk years before symptoms appear, potentially catching half of cancers earlier when treatment is most effective.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the…
Certain immune markers in mesothelioma tumors may predict which patients will benefit from combination immunotherapy, offering a path toward more personalized treatment.
Early cancer detection or preventionReal-world adoption of circulating tumor DNA testing and adjuvant…
Doctors are increasingly using blood tests to guide cancer treatment decisions, though tumor stage remains the strongest factor guiding therapy choices so far.
Near-term implementable findingPrediction of overall survival in acute myeloid leukemia using…
Machine learning models using patient data predict outcomes better than current genetic guidelines for untreated acute leukemia, suggesting clinical factors matter most.
Promising but preliminaryRisk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia.
Using matched unrelated bone marrow donors for high-risk leukemia dramatically improves survival compared to mismatched donors, especially preventing treatment-related deaths.